Press-release for stocks related to approval

Prices are updated after-hours

tags : Approval

save search

IceCure's ProSense® Deepens Regulatory Approval in India
Published: 2023-11-29 (Crawled : 19:00) - biospace.com/
ICCM | $1.03 -14.17% 0.97% 580K

Manufacturing

| Email alert Add to watchlist
prosense approval india

Proterra Receives Court Approval for Sale of Proterra Powered Business Line
Published: 2023-11-29 (Crawled : 13:30) - globenewswire.com
PTRAQ | $0.0295 -1.01% -25.09% 580K

Manufacturing

| 5.3% | O: -1.06% H: 9.64% C: -0.71%
MC | $49.22 3.73% 0.91% 610K

Finance

| 2.54% | O: 2.54% H: 0.0% C: 0.0%
business approval proterra

Aemetis Receives Environmental Approval for 24-mile Pipeline Extension to Transport Biogas from Dairy Digesters to RNG Production Facility
Published: 2023-11-29 (Crawled : 13:00) - globenewswire.com
AMTX | $4.7 5.86% 5.43% 460K

Process Industries

| -3.45% | O: 2.8% H: 0.0% C: 0.0%
approval pipeline extension

BioCardia Shares Update from Japan PMDA Consultation on CardiAMP Autologous Cell Therapy for Ischemic Heart Failure; Foreign Data Expected to be Sufficient for Product Approval
Published: 2023-11-29 (Crawled : 12:00) - globenewswire.com
BCDA | $0.6723 8.23% -0.43% 320K

Health Technology

| -5.88% | O: 0.67% H: 7.01% C: 2.35%
japan expected approval update cell cardiamp heart therapy

BioCryst Announces Approval of ORLADEYO® (berotralstat) by the National Administration of Drugs, Foods, and Medical Devices (ANMAT) in Argentina
Published: 2023-11-29 (Crawled : 12:00) - globenewswire.com
BCRX | $6.15 4.59% 4.7% 3.9M

Health Technology

| 12.0% | O: 4.57% H: 2.91% C: -1.09%
orladeyo approval medical

Timber Pharmaceuticals Receives Court Approval of All “First Day” Motions to Support Business Operations & Discloses Communication From NYSE American
Published: 2023-11-28 (Crawled : 22:00) - globenewswire.com
TMBR | $0.3426 0.74% -2.69% 0

Health Technology

| Email alert Add to watchlist
business approval pharmaceuticals communication

IntelGenx Announces Shareholder Approval of Financing Transactions
Published: 2023-11-28 (Crawled : 21:00) - globenewswire.com
IGXT | $0.1343 0.98% -0.97% 16K

Manufacturing

| -9.83% | O: -2.37% H: 4.17% C: -6.94%
approval

SpringWorks Therapeutics Announces FDA Approval of OGSIVEO™ (nirogacestat) as the First and Only Treatment for Adults with Desmoid Tumors
Published: 2023-11-27 (Crawled : 23:00) - globenewswire.com
FNCTF | $12.36 0.08% -26.03% 1K

Communications

| -2.99% | O: -2.99% H: 0.0% C: 0.0%
SWTX | $31.9 4.97% 4.64% 1.5M

Health Technology

| 29.18% | O: 10.88% H: 0.0% C: 0.0%
fda approval tumors treatment therapeutics

Mattr Announces Regulatory Approval and Expected Closing Date for Pipe Coating Business Sale
Published: 2023-11-27 (Crawled : 12:30) - globenewswire.com
TS | $34.87 0.58% 0.0% 2.7M

Non-Energy Minerals

| 1.14% | O: 0.4% H: 0.0% C: 0.0%
business expected approval

Medivir announces updated formulation of fostrox, critical to support planned study with accelerated approval intent in second line HCC
Published: 2023-11-27 (Crawled : 09:00) - prnewswire.com
IGMS S | $6.215 -7.79% -8.45% 540K

Health Technology

| 25.75% | O: -0.56% H: 2.81% C: -4.69%
approval study

Calliditas' partner Everest Medicines announces China NMPA's approval of Nefecon® for the treatment of primary IgA nephropathy
Published: 2023-11-24 (Crawled : 09:00) - biospace.com/
CALT | $17.9 3.17% -0.73% 3.9K

Health Technology

| Email alert Add to watchlist
nefecon nephropathy approval treatment china

Everest Medicines Announces China NMPA's Approval of Nefecon® for the Treatment of Primary IgA Nephropathy in Adult Patients
Published: 2023-11-24 (Crawled : 05:00) - prnewswire.com
CALT | $17.9 3.17% -0.73% 3.9K

Health Technology

| Email alert Add to watchlist
nefecon nephropathy approval treatment china

Nigerian Breweries seeks shareholders’ approval for Distell’s acquisition – Businessday
Published: 2023-11-22 (Crawled : 08:00) - spacfeed.com
CLAY | $11.45 2.14% 0.0% 100

| 0.54% | O: 0.54% H: 0.0% C: 0.0%
approval acquisition

Immix Biopharma Announces FDA Approval of IND Application for CAR-T NXC-201, Enabling U.S. Patient Dosing
Published: 2023-11-21 (Crawled : 14:30) - globenewswire.com
IMMX | $5.19 1.57% 0.78% 180K

| 15.87% | O: 1.59% H: 0.0% C: 0.0%
nxc-201 fda approval biopharma enabling application car-t

Alpha Tau Submits to Japanese PMDA for Pre-Market Approval of Alpha DaRT in Patients with Recurrent Head and Neck Cancer
Published: 2023-11-20 (Crawled : 13:30) - globenewswire.com
DRTS | $3.16 -3.66% -2.85% 23K

n/a

| 11.95% | O: 1.71% H: 3.02% C: -2.68%
approval cancer tau dart

Ascendis Pharma Announces European Commission Approval of YORVIPATH® (palopegteriparatide) for the Treatment of Adults with Chronic Hypoparathyroidism
Published: 2023-11-20 (Crawled : 13:00) - globenewswire.com
ASND | $104.05 3.61% 0.0% 780K

Health Technology

| 6.4% | O: 0.55% H: 2.21% C: -1.2%
yorvipath pharma approval treatment

Janssen Submits Supplemental Biologics License Application to U.S. FDA Seeking Approval of RYBREVANT® (amivantamab-vmjw) Plus Chemotherapy for the Treatment of Patients with EGFR-Mutated Non-Small Cell Lung Cancer Who Progressed on or after Osimertinib
Published: 2023-11-20 (Crawled : 13:00) - prnewswire.com
JNJ | $158.38 2.41% 0.0% 10M

Health Technology

| 3.86% | O: -2.06% H: 0.0% C: 0.0%
rybrevant fda lung license approval cancer cell treatment application plus

Teck Receives Regulatory Approval for Share Buy-Back Program
Published: 2023-11-20 (Crawled : 06:00) - globenewswire.com
TECK | $38.85 3.19% 1.03% 3.6M

Non-Energy Minerals